Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLCMarina Chiara Garassino, Luis Paz‐Ares, Silvia Novello et al.|JTO Clinical and Research Reports|2022Cited by 43